Key H1 FY22 highlights:
• Secured first commercial deal, licensing Weebit’s ReRAM technology to volume production with US-based semiconductor foundry SkyWater Technology Inc.
• Technology transfer to SkyWater’s US fab is on-track, with qualification to follow
• Successfully scaled down and demonstrated Weebit’s ReRAM technology at 28nm; and looking to scale down to even smaller geometries
• Raised $35.2 million to accelerate growth initiatives and technology development, with Israel-based institutional investment and pension funds investing $25.6 million
• Received first silicon demo wafers integrating Weebit’s embedded ReRAM module; a key step in allowing potential customers to test and validate Weebit’s technology
• Expanded strategic partnership with Leti to enhance ReRAM offering and support commercialisation
• Demonstrated Weebit’s first crossbar ReRAM arrays for the discrete memory market
• Filed for six new patents, further protecting intellectual property
• Progressing multiple commercial opportunities with potential partners and customers
• Appointed ReRAM and NVM expert **riel Molas as Chief Scientist
- Forums
- ASX - By Stock
- WBT
- Ann: H1 FY22 Results Release
Ann: H1 FY22 Results Release, page-2
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WBT (ASX) to my watchlist
|
|||||
Last
$1.92 |
Change
-0.005(0.26%) |
Mkt cap ! $361.7M |
Open | High | Low | Value | Volume |
$1.97 | $1.99 | $1.92 | $1.285M | 663.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 21248 | $1.92 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.92 | 4652 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 21248 | 1.915 |
6 | 31402 | 1.910 |
4 | 12440 | 1.905 |
31 | 113909 | 1.900 |
4 | 41955 | 1.890 |
Price($) | Vol. | No. |
---|---|---|
1.920 | 4652 | 1 |
1.945 | 2862 | 1 |
1.950 | 13362 | 3 |
1.955 | 22862 | 2 |
1.960 | 2862 | 1 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
NEWS
Biotech innovator secures $5.5M R&D tax incentive refund – major boost for cutting-edge programs
NEWS
First paediatric clinical site activated – major recruitment milestone and key appointment announced
WBT (ASX) Chart |